Open AccessHigh level of urokinase plasminogen activator contributes to cholangiocarcinoma invasion and metastasis
Author(s) -
Parichut Thummarati,
Sitsom Wijitburaphat,
Aruna Prasopthum,
Apaporn Menakongka,
Banchob Sripa,
Rutaiwan Tohtong,
Tuangporn Suthiphongchai
Publication year - 2012
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v18.i3.244
Subject(s) - urokinase receptor , plasminogen activator , urokinase , zymography , blot , gentamicin protection assay , cell culture , microbiology and biotechnology , biology , gene silencing , cancer research , metastasis , matrigel , plasminogen activator inhibitor 1 , chemistry , cancer , matrix metalloproteinase , biochemistry , endocrinology , gene , genetics
To investigate the role of urokinase plasminogen activator (uPA) in cholangiocarcinoma (CCA) invasion and its correlation with clinicopathological parameters.